Jason is Head of the Hepatitis C and Drug Use Group in the Viral Hepatitis Clinical Research Program at the Kirby Institute, UNSW Sydney. Jason's training and research is based in the field of epidemiology, with a focus on clinical epidemiology. Jason has a BSc in Biochemistry and Molecular Biology and a PhD in Pharmacology and Therapeutics, both from the University of British Columbia in Vancouver, Canada. He completed a Postdoctoral Fellowship in Clinical Epidemiology at the University of New South Wales in Sydney, Australia. Jason is also the President of the International Network on Hepatitis in Substance Users.
Epidemiology and natural history of hepatitis C virus infection, acute hepatitis C virus infection, barriers to care for hepatitis C virus infection, strategies for enhancing assessment and treatment of hepatitis C virus infection in people who use drugs. I am also interested in other harms that may relate to injecting drug use, including overdose and other injecting-related infections, and interventions to reduce potential harms, including naloxone and treatment for drug dependency.
Broad Research Areas:
Clinical Research, Infectious Diseases, Epidemiology, Population Health, Gastrointestinal Diseases
Society Memberships & Professional Activities:
Member, Australasian Society for HIV Medicine; Member, European Association for the Study of the Liver (EASL); Member, American Association for the Study of Liver Disease (AASLD); Member, Canadian Association for the Study of Liver Disease (CASL).
Specific Research Keywords:
Hepatitis C virus, Access to health care, Clinical Epidemiology, Injecting drug use, Clinical trials